Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc. ...Middle East

NEW YORK, May 24, 2022 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ: BIOT) ("BAC"), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, today announced that it has made a submission to the United States Securities and Exchange Commission...

Hence then, the article about biotech acquisition company announces submission of prospectus supplement to the proxy statement prospectus to the registration statement on form s 4 related to proposed merger with blade therapeutics inc was published today ( Tuesday 24/05/2022 - 04:24 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc. )

Also on site :

• France to ditch American video conferencing services
• EU’s Kallas privately complaining about ‘dictator’ von der Leyen – Politico
• Bob Iger Just Walked the Site of Disney’s Next Theme Park